MétaCan
Menu
Back to cohort
Record W4229059699 · doi:10.1093/ndt/gfac072.004

MO522: The Effect of Statin on Anemia in Patients With End-Stage Kidney Disease Receiving Hemodialysis: A Systematic Review and Meta-Analysis

2022· review· en· W4229059699 on OpenAlexaboutno aff
Yen‐Chung Lin

Bibliographic record

VenueNephrology Dialysis Transplantation · 2022
Typereview
Languageen
FieldMedicine
TopicErythropoietin and Anemia Treatment
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineInternal medicineRandomized controlled trialHemodialysisKidney diseaseAnemiaCochrane LibraryStatinMeta-analysisCohort studyCohort

Abstract

fetched live from OpenAlex

Abstract BACKGROUND AND AIMS Although treatment with erythropoietin-stimulating agents is effective in treating anemia in patients with end-stage kidney disease undergoing hemodialysis, some uremia patients, especially those with inflammation, continue to suffer from anemia. HMG-CoA reductase inhibitors (statins), which are lipid-lowering agents, may have a pleiotropic effect in reducing inflammation. Hence, we investigated the role of statin on hemoglobin (Hb) in patients receiving hemodialysis. METHOD We searched the PubMed, Embase, Medline, and Cochrane databases by using predefined keywords and MeSH terms for randomized controlled trials or cohort studies. Studies were included if (1) participants with CKD/ESKD were included, (2) treatment arms with statins were included, (3) study type was randomized control trial/cohort study and (4) outcomes of interest were hemoglobin (Hb), erythropoietin resistance index (ERI) and ferritin. Risk of bias tool 2.0 and the Newcastle–Ottawa Scale (NOS) were utilized to assess risk of bias in randomized controlled trials and cohort studies, respectively. Egger's test was used to test publication bias. In addition, our study was reported according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020 statement. RESULTS We eventually included 10 studies (5258 participants), comprising three randomized controlled trials and seven cohort studies. Overall, Hb increased by 0.84 g/dL [95% confidence interval (95% CI) −0.02–1.70] in all groups of using statins, including single-arm cohorts, and by 0.72 g/dL (95% CI −0.02–1.46) in studies with placebo control. Hb levels were higher in the study group than in the control group, with a mean difference of 0.18 (95% CI 0.04–0.32) at baseline and 0.86 (95% CI 0.74–0.99) at the endpoint. Ferritin increased by 9.97 mg/dL (95% CI −5.36–25.29) in the study group and decreased by 34.01 mg/dL (95% CI −148.16–80.14) in the control group; ferritin fluctuation was higher in the control group. CONCLUSION Statin may improve renal anemia in patients with CKD and receiving regular erythropoietin-stimulating agents. Future studies with more rigorous methodology and larger sample size study should be performed to confirm this beneficial effect.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.011
metaresearch head score (Gemma)0.023
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.020
Threshold uncertainty score0.057

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0110.023
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0200.037
Bibliometrics0.0070.007
Science and technology studies0.0010.001
Scholarly communication0.0030.002
Open science0.0020.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.291
Teacher spread0.271 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueNephrology Dialysis TransplantationSame topicErythropoietin and Anemia TreatmentFrench-language works237,207